Pan, Xiao | Search NASA

DOE OSTI2022

Performance of three Trichogramma species as biocontrol agents on Spodoptera frugiperda eggs

Abstract Spodoptera frugiperda (JE Smith) (Lepidoptera: Noctuidae) is one of the most polyphagous and migratory pests posing a great threat to crops. The Trichogramma species (Hymenoptera: Trichogrammatidae) play an important role in dampening pest oscillations. In this study, we examined the performance of three egg parasitoids, T. chilonis , T. dendrolimi and T. pretiosum, to control S. frugiperda . Indoor experiments indicated significant differences in fecundity and female proportion between T. chilonis , T. dendrolimi and T. pretiosum . However, no significant differences were observed in developmental duration and female parasitic capacity. Field trials were carried out to clarify their control efficiency. Results showed that the parasitism rates of three parasitoids ranged from 10.7% to 31.4%, without significant differences. Moreover, field release of parasitoids resulted in significant decreases in damage rate (the ratio of infested plants) and damage index. A positive correlation was revealed between temperature (14.5–24.5 °C) and parasitism rate of T. chilonis . In contrast, the relative humidity (66% ~ 77%) did not affect their performance. Taken together, all three Trichogramma species can be used as potential agents to control S. frugiperda , which undoubtedly lays a solid foundation for their application.

Yang, Lei↗

DOE OSTI2021

Screening and Validation of Molecular Targeted Radiosensitizers

The development of molecular targeted drugs with radiation and chemotherapy is critically important for improving the outcomes of patients with hard-to-treat, potentially curable cancers. However, too many preclinical studies have not translated into successful radiation oncology trials. Major contributing factors to this insufficiency include poor reproducibility of preclinical data, inadequate preclinical modeling of intertumoral genomic heterogeneity that influences treatment sensitivity in the clinic, and a reliance on tumor growth delay instead of local control (TCD50) endpoints. There exists an urgent need to overcome these barriers to facilitate successful clinical translation of targeted radiosensitizers. To this end, we have used 3-dimensional (3D) cell culture assays to better model tumor behavior in vivo. Examples of successful prediction of in vivo effects with these 3D assays include radiosensitization of head and neck cancers by inhibiting epidermal growth factor receptor or focal adhesion kinase signaling, and radioresistance associated with oncogenic mutation of KRAS. To address the issue of tumor heterogeneity, we leveraged institutional resources that allow high-throughput 3D screening of radiation combinations with small-molecule inhibitors across genomically characterized cell lines from lung, head and neck, and pancreatic cancers. This high-throughput screen is expected to uncover genomic biomarkers that will inform the successful clinical translation of targeted agents from the National Cancer Institute Cancer Therapy Evaluation Program portfolio and other sources. Screening “hits” need to be subjected to refinement studies that include clonogenic assays, addition of disease-specific chemotherapeutics, target/biomarker validation, and integration of patient-derived tumor models. The chemoradiosensitizing activities of the most promising drugs should be confirmed in TCD50 assays in xenograft models with or without relevant biomarker and using clinically relevant radiation fractionation. We predict that appropriately validated and biomarker-directed targeted therapies will have a higher likelihood than past efforts of being successfully incorporated into the standard management of hard-to-treat tumors.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

DOE OSTI2021

Regional Climates

Explore the source record for details and available documents.

54 ENVIRONMENTAL SCIENCES↗